Ontamalimab Uses, Dosage, Side Effects and more
Ontamalimab is under investigation in clinical trial NCT03627091 (Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)).
| Trade Name | Ontamalimab |
| Generic | Ontamalimab |
| Ontamalimab Other Names | Ontamalimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
